A TOR KINASE INHIBITOR IN THE PREVENTION OR TREATMENT OF CANCER CHARACTERIZED BY GENE MUTATIONS.

摘要

Provided herein are methods for treating and/or preventing a cancer in a patient, comprising administering an effective amount of a TOR kinase inhibitor to a patient having cancer characterized by particular gene mutation(s) or variant(s) relative to the genes of a biological wild-type sample.